FinDogFinDog
Wednesday, September 16, 2026Closing data · 4:00 PM ET
English
Log in

HSIC

Henry ScheinNASDAQ · Health Care Distributors · Health Care
Previous close
86.77
Change
−0.75 / −0.86%
FinDog View
Bullish
52-Week Range
61.95 – 92.18
P/E (TTM)
24.2
Forward P/E
15.1
Based on consensus earnings for the next 12 months
Market Cap
$9.7B
1M
−3.07%
S&P 500 −2.41% over same period
Volume / Avg Volume
1.0M / 954K
1.07× average

Price History

Closing price · USD1M6M1Y5Y
60708090100FY26 Q2 EarningsFY26 Q1 Earnings2026-032026-052026-062026-082026-09

Historical P/E

Close ÷ trailing four-quarter EPS · Period median 23.51M6M1Y5Y
15202530352023-082024-052025-032025-122026-09

Recent Earnings

Click to read the FinDog analysis
PeriodReportedRevenueEPS Actual / Est.Next-Day MoveAnalysis
FY2026 Q2
Quarter ended 2026-06
2026-08-04$3.5B1.27 / 1.26+0.54%Read analysis →
FY2026 Q1
Quarter ended 2026-03
2026-05-05$3.4B1.32 / 1.24−2.60%Pending
FY2025 Q4
Quarter ended 2025-12
2026-02-24—— / —−1.73%Pending
FY2025 Q3
Quarter ended 2025-09
2025-11-04$3.3B1.38 / 1.30+0.56%Pending
FY2025 Q2
Quarter ended 2025-06
2025-08-05$3.2B1.10 / —+2.29%Pending
FY2025 Q1
Quarter ended 2025-03
2025-05-05—— / —−0.51%Pending

Decision Panel

Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market data
Valuation
P/E is at percentile 57 of its 5-year rangeMid-range
5-year range 20.3 – 30.6 · Median 23.5
Last 4 quarters: $728M in buybacks + $0 in dividends, 7.53% of market cap combined
P/E (TTM)
24.2
P/B
3.1
P/S
0.7
PEG
1.65
Earnings Reaction
Over the last 6 reports, the stock moved ±1.4% on average on the first trading day after, rising 3 times
Most recent +0.54%
Volatility & Correlation
1-year beta 0.52 · Correlation with S&P 500 0.26Low beta
Annualized volatility 26% vs. 13% for the S&P 500
Insider Trading
View all →
Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
No open-market buys or sells by officers or directors in the last 90 days.
Multi-Quarter Financial Trends
View all quarters →
Last 12 quarters · As reported by the company
QuarterRevenue ($B)YoYGross MarginOperating Income ($B)Net Income ($B)Free Cash Flow ($B)EPS
FY2026 Q23.46+6.7%31.8%0.170.090.240.82
FY2026 Q13.37+6.3%31.8%0.180.11-0.100.92
FY2025 Q43.44+7.7%30.9%0.160.120.380.85
FY2025 Q33.34+5.2%30.7%0.160.100.170.84
FY2025 Q23.24+3.3%31.4%0.150.090.120.70
FY2025 Q13.17−0.1%31.6%0.180.110.040.88
FY2024 Q43.19+5.8%31.1%0.160.100.200.75
FY2024 Q33.17+2.4%31.3%0.160.100.150.78
FY2024 Q23.14+2.5%32.5%0.160.100.300.80
FY2024 Q13.17—31.9%0.150.090.200.72
FY2023 Q43.02−10.5%30.6%0.040.04-0.030.14
FY2023 Q33.10+1.1%31.5%0.200.140.271.06

Peers

Largest by market cap in the sector · Latest quarterView Health Care sector →
TickerCompanyMarket CapP/ERevenue YoYGross Margin1MView
HSICHenry Schein$9.7B24.2+6.7%31.8%−3.07%Bullish
LLYLilly (Eli)$1.07T39.9+47.7%85.8%−3.83%BullishCompare
JNJJohnson & Johnson$644B30.6+6.6%68.2%+1.87%BullishCompare
ABBVAbbVie$464B73.7+10.2%74.7%+4.87%NeutralCompare
MRKMerck & Co.$358B112.2+5.1%73.5%+6.57%NeutralCompare
UNHUnitedHealth Group$337B23.9+0.4%88.1%−5.15%NeutralCompare
TMOThermo Fisher Scientific$240B34.4+10.5%—+10.75%BullishCompare
AMGNAmgen$203B23.3+9.5%72.0%−10.26%NeutralCompare
GILDGilead Sciences$183B—+10.2%79.8%+6.31%NeutralCompare